SARS CoV 2 News and Research

RSS

Study finds stable T-Cell response against Omicron after mRNA booster vaccination

A new study measured T cell activity in vaccinated individuals and found a third vaccine provided substantial T-cell immunity against the Omicron variant of SARS-CoV-2.

24 Jan 2022

Causal impact of spontaneous relaxation of social distancing practices on spread of SARS-CoV-2 in US

The purpose of a recent study was to examine the causal impact of a spontaneous relaxation of social distancing measures on the spread of SARS-CoV-2.

24 Jan 2022

Research shows depletion of extracellular vesicles weakens immune response towards SARS-CoV-2

Over the past several years, considerable effort has been made towards developing better diagnostic and prognostic tools. However, until now, the focus of research has mainly been on the virus itself or the immune response it triggers. To unify diagnostic and prognostic tools for COVID-19 analyses, researchers propose using extracellular vesicles (EVs) from serum liquid biopsies.

24 Jan 2022

Researchers are in the race to beat Omicron

David Veesler and his lab members aren't getting much sleep these days. In the final weeks of 2021, he and his team worked around the clock to post four coronavirus papers on the preprint server bioRxiv.

24 Jan 2022

Researchers find ELF5 gene a leading candidate behind severe COVID-19

Are there any risk factors that predispose patients to severe COVID-19 outcomes? A recent study published in the medRxiv* preprint server sheds light on this popular question. Using a combination of population genetics to single-cell RNA sequencing, European researchers identified the respiratory epithelial cell-specific ELF5 gene as a potential mediator for severe COVID-19 cases.

24 Jan 2022

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

A recent study published in the journal Science brings a detailed chemical and molecular perspective on the improved evasion of antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the retention of strong interactions with the receptor as two principal factors underneath the notorious transmissibility of the SARS-CoV-2 Omicron variant.

23 Jan 2022

An algorithm to predict host cleavage targets of SARS-CoV-2 3CLPro

In a recent study posted to the bioRxiv* preprint server, researchers developed a novel bioinformatic algorithm to predict host cleavage targets of the SARS-CoV-2 3C-like protease (3CLPro).

23 Jan 2022

Nirmatrelvir, Molnupiravir, and Remdesivir hold-up against SARS-CoV-2 Omicron variant in vitro

In a recent study posted to the bioRxiv* preprint server, researchers test three severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antivirals authorized for emergency use by the United States Food and Drug Administration (FDA) for their in vitro potency against several SARS-CoV-2 variants, including the currently dominant Omicron train.

23 Jan 2022

Genetic marker linked to higher risk of death in COVID-19 patients

A new study discusses the importance of single nucleotide polymorphisms in the Rab46 gene as a marker of adverse outcomes in high-risk COVID-19 patients.

23 Jan 2022

Novel SARS-CoV-2 mutations reported in chronic HIV patients

A new study describes the emergence of new SARS-CoV-2 variants in three immunocompromised patients.

23 Jan 2022

Robust BNT162b2 vaccine-induced B and T-cell immunity against early SARS-CoV-2 variants

Researchers describe the state of adaptive immunity following vaccination with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.

23 Jan 2022

CoronaVac provides herd immunity in region of the Colombian Amazon

Researchers determine the effectiveness of the CoronaVac® vaccine in a Colombian Amazon population.

23 Jan 2022

SARS-CoV-2 Omicron associated with fewer lower and more upper respiratory tract symptoms

Researchers assess the impact of the SARS-CoV-2 Omicron variant of concern on symptoms of SARS-CoV-2 infection.

23 Jan 2022

Paxlovid provides a glimpse into the future against SARS-CoV-2

A recent study reveals that nirmatrelvir is potent and effective against the SARS-CoV-2 Omicron variant.

23 Jan 2022

Determining evolution of COVID-19 mortality rates using machine-learning

Researchers predict the evolution of COVID-19 mortality rates across countries using a biological science-guided machine learning-based approach.

23 Jan 2022

Impact of booster vaccines against SARS-CoV-2 Omicron variant

Researchers explore the dynamics of COVID-19 vaccine-induced protection against SARS-CoV-2 variants of concern.

23 Jan 2022

U.S. EPA and WHO sign agreement protect the public from health risks of pollution

This week, the U.S. Environmental Protection Agency and World Health Organization signed a five-year Memorandum of Understanding.

22 Jan 2022

Researchers call for tailored public health messaging about COVID-19 vaccination for HIV patients

While most people living with HIV have received at least one dose of the COVID-19 vaccine, younger and Black individuals are hesitant to get vaccinated and have lower vaccination rates, according to a new study by Rutgers researchers.

22 Jan 2022

MU researchers identify highly prevalent mutations specific to Omicron variant

While the Omicron variant continues to infect people around the world, researchers at the University of Missouri have identified the highly prevalent, specific mutations that are causing the Omicron variant's high rate of infection.

22 Jan 2022

Many care home residents, staff tested positive for Covid-19 during the first two waves of the pandemic

More than a third of care home residents and a quarter of care home staff in England showed evidence of infection with SARS-CoV-2 during the first two waves of the pandemic, according to a new study led by UCL (University College London) researchers.

22 Jan 2022

SARS CoV 2 News and Research

Study finds stable T-Cell response against Omicron after mRNA booster vaccination

Causal impact of spontaneous relaxation of social distancing practices on spread of SARS-CoV-2 in US

Research shows depletion of extracellular vesicles weakens immune response towards SARS-CoV-2

Researchers are in the race to beat Omicron

Researchers find ELF5 gene a leading candidate behind severe COVID-19

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

An algorithm to predict host cleavage targets of SARS-CoV-2 3CLPro

Nirmatrelvir, Molnupiravir, and Remdesivir hold-up against SARS-CoV-2 Omicron variant in vitro

Genetic marker linked to higher risk of death in COVID-19 patients

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Robust BNT162b2 vaccine-induced B and T-cell immunity against early SARS-CoV-2 variants

CoronaVac provides herd immunity in region of the Colombian Amazon

SARS-CoV-2 Omicron associated with fewer lower and more upper respiratory tract symptoms

Paxlovid provides a glimpse into the future against SARS-CoV-2

Determining evolution of COVID-19 mortality rates using machine-learning

Impact of booster vaccines against SARS-CoV-2 Omicron variant

U.S. EPA and WHO sign agreement protect the public from health risks of pollution

Researchers call for tailored public health messaging about COVID-19 vaccination for HIV patients

MU researchers identify highly prevalent mutations specific to Omicron variant

Many care home residents, staff tested positive for Covid-19 during the first two waves of the pandemic

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News